Biocon shares rise 2.48% in early trade, hit new 52-week high

Biocon shares demonstrated positive movement in Wednesday's early trading session, with the stock price increasing by 2.48% to reach Rs 400.15. The stock hit a new 52-week high. This increase reflects a positive shift in investor sentiment towards the stock during the session. The stock is included as one of the stocks in the NIFTY MIDCAP 150 index.

Financial Snapshot:

The following table summarizes the key financial data for Biocon:

ParticularsMar 2025Mar 2024Mar 2023Mar 2022

Mar 2021Revenue (Rs Crore)Rs 15,261.70 CroreRs 14,755.70 CroreRs 11,174.20 CroreRs 8,184.00 Crore

Rs 7,105.80 CroreNet Profit (Rs Crore)Rs 1,429.40 CroreRs 1,382.00 CroreRs 810.00 CroreRs 978.50 Crore

Rs 925.40 CroreEPS8.468.553.885.44

6.24BVPS180.28210.51187.3178.87

70.09ROE4.685.162.587.69

9.83Debt to Equity0.820.800.990.58

0.47

The company has demonstrated consistent growth in revenue over the past five years. The revenue for the year ending March 2025 stood at Rs 15,261.70 Crore, a 36.56% increase compared to the year ending March 2021. Net profit also increased from Rs 925.40 Crore in March 2021 to Rs 1,429.40 Crore in March 2025.

The quarterly financial performance shows a revenue of Rs 4,417.00 Crore for the quarter-ending March 2025, compared to Rs 3,917.10 Crore for the quarter-ending March 2024. The net profit for the quarter-ending March 2025 was Rs 459.40 Crore, compared to Rs 225.60 Crore for the quarter-ending March 2024.

The company's income statement provides a detailed breakdown of its financial performance. Sales increased from Rs 7,105 Crore in March 2021 to Rs 15,261 Crore in March 2025. The net profit for the same period increased from Rs 925 Crore to Rs 1,429 Crore.

Key financial ratios for Biocon show a P/E ratio of 40.39 and a P/B ratio of 1.89 as of March 2025. The company reported a debt-to-equity ratio of 0.82 as of the year-ending March 2025.

Corporate Actions:

Biocon has announced a final dividend of Rs 0.50 per share (10%) with effective date 04 Jul, 2025. The company had announced bonus issues on multiple occasions, including a 1:1 bonus on April 25, 2019, with exbonus date of 12 Jun, 2019.With the stock currently priced at Rs 400.15, Biocon shows a positive trend in today's early trading session on NIFTY MIDCAP 150.